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A B S T R A C T 
Introduction: The mortality rate after oesophageal 
perforation is high despite advances in operative and 
non-operative techniques. In this study, we sought 
to identify risk factors for hospital mortality after 
oesophageal perforation treatment.
Methods: We retrospectively examined patients 
treated for oesophageal perforation in a university 
teaching hospital in Hong Kong between January 
1997 and December 2013. Their demographic and 
clinical characteristics, aetiology, management 
strategies, and outcomes were recorded and 
analysed. 
Results: We identified a cohort of 43 patients treated 
for perforation of the oesophagus (28 men; median 
age, 66 years; age range, 30-98 years). Perforation 
was spontaneous in 22 (51.2%) patients (15 with 
Boerhaave’s syndrome and seven with malignant 
perforation), iatrogenic in 15 (34.9%), and provoked 
by foreign body ingestion in six (14.0%). Of the 
patients, 14 (32.6%) had pre-existing oesophageal 
disease. Perforation occurred in the intrathoracic 
oesophagus in 30 (69.8%) patients. Emergent surgery 
was undertaken in 23 patients: 16 underwent 
primary repair, six surgical drainage or exclusion, 
and one oesophagectomy. Twenty patients were 
managed non-operatively, 13 of whom underwent 
stenting. Two stented patients subsequently 
required oesophagectomy. Four patients had clinical 
signs of leak after primary repair: two were treated 
conservatively and two required oesophagectomy. 
Outcomes after oesophageal perforation:  
a retrospective cohort study of patients with 
different aetiologies
Introduction
Oesophageal perforation is uncommon, yet its 
management remains a substantial challenge to 
surgeons. Diagnosis and treatment are often delayed 
due to lack of clinical suspicion and accurate 
diagnostic tools. Hence, reported mortality rates 
range from 10% to 25%.1-3 
New knowledge added by this study
• We report the outcomes of a cohort of patients with oesophageal perforation managed in a single centre.
• Mortality rate was substantial despite advances in surgery and endoscopic therapy. 
Implications for clinical practice or policy
• Surgical and non-operative treatment options are available. 
• The aetiology, timing of presentation, and patients’ co-morbidities should be considered carefully when 
managing oesophageal perforation. 
• Oesophagectomy may be indicated in selected patients.
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 Oesophageal perforation can occur 
spontaneously from forceful vomiting (Boerhaave’s 
syndrome), or in pre-existing pathology (such as 
oesophageal cancer) or can be associated with 
ingestion of a foreign body. Iatrogenic perforation 
usually occurs after therapeutic endoscopic 
procedures such as dilatation, and is the predominant 
ORIGINAL ARTICLECME
Overall, six (14.0%) patients required 
oesophagectomy, one of whom died. Nine other 
patients also died in hospital; the hospital mortality 
rate was 23.3%. Pre-existing pulmonary and hepatic 
disease, and perforation associated with malignancy 
were significantly associated with hospital mortality 
(P=0.03, <0.01, and <0.01, respectively). 
Conclusions: Most oesophageal perforations 
were spontaneous. Mortality was substantial 
despite modern therapies. Presence of pre-existing 
pulmonary disease, hepatic disease, and perforation 
associated with malignancy were significantly 
associated with hospital mortality. Salvage 
oesophagectomy was successful in selected patients. 
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有不同病因的食管穿孔患者的治療結果： 
回顧性隊列研究
羅芷婷、陳應倫、陳君傑、唐琼雄、黃宇匡、陳小燕、羅英傑
引言：儘管食管穿孔的手術和非手術治療技術不斷進步，但此病的死
亡率仍然偏高。本研究旨在找出食管穿孔患者醫院死亡率的危險因
素。
方法：回顧分析1997年1月至2013年12月期間在香港一所大學教學
醫院內接受食管穿孔治療的患者。記錄分析病人資料、臨床特徵、病
因、治療策略和結果。
結果：研究期間有43例食管穿孔，患者年齡介乎30-98歲，中位數66
歲；其中28名為男性。患者中自發性食管穿孔佔22例（51.2%），
包括Boerhaave綜合徵15例和惡性穿孔7例；醫源性食管穿孔的有15
例（34.9%）；食管異物致穿孔的有6例（14.0%）。患者中有14例
（32.6%）有食管病病史。胸段食管穿孔的有30例（69.8%）。有23
例進行急診手術，包括16例修補、6例引流或排除和1例食管切除。
接受非手術治療的20例中，有13例食管支架置入；其中2例曾接受
支架置入的患者隨後須接受食管切除。4例患者接受食管修補後有臨
床滲漏，當中2例隨後接受保守治療，另2例接受食管切除。總體而
言，6例（14.0%）須進行食管切除，其中1例死亡；另有9例在醫院
內死亡。醫院死亡率為23.3%。有肺病病史（P=0.03）、肝病病史
（P<0.01），以及與惡性腫瘤有關的食管穿孔（P<0.01）與醫院死亡
率顯著相關。
結論：大多數食管穿孔的病例屬自發性。儘管現代技術不斷進步，食
管穿孔的死亡率仍然偏高。有肺病和肝病病史，以及與惡性腫瘤有關
的食管穿孔均與醫院死亡率顯著相關。補救性食管切除在部分患者中
有成效。
cause of perforation reported in many studies.1,2,4,5
 Diagnosis and treatment within 24 hours of 
perforation are critical if favourable outcomes are to 
be achieved.1,6 After diagnosis and the initial phase 
of resuscitation, there is a wide range of treatment 
options, which are informed by the presentation, 
aetiology, location of perforation, and the extent of 
mediastinal or intrathoracic contamination. Surgery 
remains the mainstay of treatment; the conventional 
operative approach is considered to be primary 
repair of the perforation site and drainage.7-9 Some 
surgeons advocate primary repair only for those 
patients presented within 24 hours of perforation,10 
while others would try primary repair as the initial 
treatment regardless of the timing of presentation.9,11 
Endoscopic treatment, including stenting, is 
becoming an increasingly popular means of treating 
oesophageal perforation in selected patients, and 
reportedly has a high technical success rate.12-16 
 Oesophageal perforation should be managed 
in specialised centres. In this study, we report the 
characteristics, treatment, and outcomes of a cohort 
of patients with oesophageal perforation treated at a 
single tertiary centre in Hong Kong over a period of 
16 years. 
Methods
We retrospectively identified patients treated 
for perforation of the oesophagus at a university 
teaching hospital in Hong Kong between January 
1997 and December 2013. Patients’ demographic 
characteristics, presentation, investigations, 
management, and outcomes were recorded. 
 Diagnosis of perforation was confirmed 
by one or more of the following methods: 
oesophagogastroduodenoscopy (OGD), water-
soluble contrast swallow study, and contrast-
enhanced computed tomography imaging of the 
neck, thorax, and abdomen. After confirmation of 
the diagnosis, patients were resuscitated to address 
homoeostatic and haemodynamic disturbances, 
followed by definitive treatment. All patients were 
kept ‘nil by mouth’, administered parenteral broad-
spectrum antibiotics and proton pump inhibitors, 
and chest drain(s) was inserted if clinically indicated. 
Patients with significant haemodynamic instability 
or respiratory distress requiring intubation and 
mechanical ventilation were admitted to the 
intensive care unit (ICU) for optimisation before 
definitive treatment. 
 Definitive treatment depended on the location 
of the perforation, its aetiology, the extent of 
mediastinal and intrathoracic contamination, and 
the patient’s physical status. In general, patients 
with malignant perforation or perforation contained 
within the mediastinal pleura were treated non-
operatively. For the former, self-expanding metallic 
stents were inserted under fluoroscopic guidance. In 
selected patients with a benign cause of perforation 
and limited contamination, a polyester oesophageal 
stent (Polyflex; Boston Scientific, Natick [MA], United 
States) was placed under fluoroscopic guidance. For 
patients in whom the site of perforation could not 
be identified, and in the absence of clinical signs 
of sepsis, a conservative management strategy was 
adopted. This entailed placement of a nasogastric 
feeding tube under endoscopic guidance, followed 
by enteral feeding for 7 days. Thereafter, a water-
soluble contrast swallow study was undertaken to 
confirm the absence of a leak before oral feeding was 
resumed. 
 When a surgical management strategy 
was decided, patients with perforation of the 
intra-abdominal oesophagus were treated with 
laparotomy, primary repair of the perforation, 
and feeding jejunostomy. For an intrathoracic 
perforation with significant contamination of the 
pleural cavity, thoracotomy and primary repair was 
the preferred approach. A left-sided thoracotomy 
was the usual approach for Boerhaave’s perforation 
of the distal thoracic oesophagus. Necrotic tissue 
was debrided, the edges of the perforation were 
trimmed, and the defect was closed with fine sutures 
in two layers. The mucosal edges of the perforation 
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were approximated using interrupted absorbable 
sutures, and the muscular defect was approximated 
using interrupted monofilament absorbable sutures. 
Lung decortication was performed. One drain was 
placed in close proximity to the repair, generally 
accompanied by one basal and one apical large-bore 
chest drain. Feeding jejunostomy was performed in 
selected patients. Postoperatively patients remained 
nil by mouth, and were given nutritional support and 
intravenous antibiotics. A contrast swallow study 
was generally performed 7 to 10 days postoperatively; 
oral intake was commenced if there was no evidence 
of leak. The choice of antibiotics and duration of 
treatment were guided by microbiology culture 
findings. 
 In selected patients who presented late, and 
in those who developed a persistent leak after 
primary repair, oesophageal exclusion (cervical 
oesophagostomy and jejunostomy) followed by 
second-stage oesophagectomy might be considered. 
In the first stage, the oesophagus was excluded 
proximally in the neck with an oesophagostomy, and 
the abdominal oesophagus was stapled. A drain was 
placed from the neck into the oesophageal stump for 
decompression. Oesophagectomy was performed 
once sepsis had subsided. A gastric tube was used 
for reconstruction via the retrosternal route, and 
cervical oesophagogastrostomy was performed. 
 The principles outlined in the Declaration of 
Helsinki have been followed. 
Statistical analysis
Continuous data were represented as the median 
(range), unless otherwise stated. Fisher’s exact test 
was used to compare categorical variables and the 
Mann-Whitney U test for continuous variables. 
We undertook univariate analysis to identify 
factors associated with hospital mortality. P<0.05 
was considered statistically significant. Data were 
analysed using SPSS 20.0 (IBM Corp, Armonk [NY], 
United States).
Results
During the study period, 43 patients with 
oesophageal perforation were identified. Patients’ 
demographic and clinical characteristics are 
summarised in Table 1. The median age of the 
cohort was 66 years (range, 30-98 years); 28 (65.1%) 
were men. Medical co-morbidities were present in 
27 (62.8%) patients, and pre-existing oesophageal 
pathologies were present in 14 (32.6%; of whom half 
had oesophageal cancer). Spontaneous perforation 
occurred in 22 (51.2%) patients: 15 occurred as a 
result of Boerhaave’s syndrome and seven as a result 
of malignant perforation. Fifteen (34.9%) patients 
had an iatrogenic perforation: 13 occurred after 
an endoscopic procedure (three after endoscopic 
retrograde cholangiopancreatography and 10 after 
OGD), one occurred after attempted endotracheal 
intubation, and one occurred during thyroidectomy. 
Of the 10 OGDs, eight had been therapeutic. Six 
(14.0%) perforations were associated with ingestion 
of a foreign body. 
 Chest pain and vomiting were the most 
common presenting symptoms in patients with 
spontaneous perforation, occurring in 13 and 10 
patients, respectively. Surgical emphysema and 
TABLE 1.  Patients’ clinical and demographic characteristics
Characteristic Data*
Sex	(M:F) 28:15
Age	(years) 66	(30-98)
Medical	co-morbidities	 27	(62.8)
Site	of	oesophageal	perforation	
Cervical 10	(23.3)
Thoracic	 30	(69.8)
Abdominal 3	(7.0)
Pre-existing	oesophageal	pathology	 14	(32.6)
Initial	treatment
Operative 23	(53.5)
Non-operative 20	(46.5)
Intensive	care	unit	stay	(days) 6	(0-71)
Hospital	stay	(days) 36.5	(6-241)
Hospital	mortality 10	(23.3)
30-Day	mortality 7	(16.3)
* Data are shown as No. of patients, No. (%) of patients, or 
median (range)
TABLE 2.  Presenting symptoms* in patients with spontaneous 
perforation, and investigations undertaken in all patients
No. of patients with 
spontaneous perforation (n=22)
Chest	pain 13	
Epigastric	pain 6 
Dysphagia 2	
Vomiting/haematemesis 10	
Respiratory	distress	 6 
Surgical	emphysema	 2	
Time	to	diagnosis	
≤24	Hours	 12
>24	Hours	 10
Investigations† (n=43)
One	modality 9	(20.9%)
Two	modalities 29	(67.4%)
Three	modalities 5	(11.6%)
* Patients might have presented with more than one symptom
† Oesophagogastroduodenoscopy, computed tomography,  
and/or contrast swallow study
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dysphagia were the least common presenting signs 
and symptoms; both were only present in two 
patients. Over half the patients presented and were 
diagnosed within 24 hours of symptom onset. Of 
the cohort of 43 patients, 29 (67.4%) underwent two 
out of the three diagnostic imaging modalities. The 
presenting symptoms and investigations of patients 
with spontaneous perforation are shown in Table 2. 
 The management and outcomes of patients 
are shown in the Figure. Of the 15 patients with 
Boerhaave’s perforation, 10 underwent primary 
repair: four repairs were complicated by a leak and 
two patients subsequently required oesophagectomy. 
The remaining five patients were initially treated 
non-operatively: four underwent endoscopic stent 
placement and one endoscopic clipping of the 
perforation. Three patients required subsequent 
operations: one underwent oesophagectomy, 
one bypass operation, and one surgical drainage. 
There were no deaths in the group of patients with 
Boerhaave’s syndrome. 
 Seven patients had malignant perforation: 
five were treated with endoscopic placement of 
a metallic stent. All but one of these procedures 
were successful; the patient in whom stenting failed 
underwent oesophagectomy. Five (71.4%) of the 
seven patients with malignant perforation died 
during their hospital stay.
 There were 15 iatrogenic perforations (Fig). 
Nine of these patients underwent early operative 
treatment: five underwent primary repair, one 
exclusion, two drainage, and one oesophagectomy. 
There were no leaks in those who underwent primary 
repair. Six patients were initially treated non-
operatively, four with stents, one with a feeding tube, 
and one was judged to be unfit for treatment. Two 
of the six patients initially treated non-operatively 
ultimately required surgery, one underwent 
FIG.  Outcomes of patients with oesophageal perforation according to treatment algorithm
* Two failed stents and one failed clip
† This case was a staged procedure after exclusion
‡  These came from the stent group
Oesophageal 
perforation 
(n=43)
Boerhaave’s 
syndrome 
(n=15)
Malignant 
perforation 
(n=7)
Spontaneous 
(n=22)
Operative:
Primary repair (n=10) Operative:
Oesophagectomy (n=2)
Non-operative:
Stent (n=4)
Clip (n=1)
Operative:
Oesophagectomy (n=1)
Bypass (n=1)
Drainage (n=1)
Non-operative:
Stent (n=4)
Conservative (n=1)
Operative:
Exclusion (n=1)
Drainage (n=1)
Non-operative:
Conservative (n=3)
Operative:
Primary repair (n=5)
Exclusion (n=1)
Drainage (n=2)
Oesophagectomy (n=1)
Operative:
Primary repair (n=1)
Exclusion (n=1)
Drainage (n=1)
Operative:
Drainage (n=1)
Non-operative:
Stent (n=5)
Operative:
Oesophagectomy (n=1)
Operative:
Oesophagectomy (n=1)
No treatment (n=1)
Conservative (n=2)
Leak (n=4)
Failed (n=3)*
Failed (n=1)
Failed (n=1)†
Failed (n=2)‡
No treatment (n=1)
Iatrogenic 
(n=15)
Foreign body 
ingestion (n=6)
Initial treatment Salvage treatment
Further treatment
Hospital 
mortality
0 (0%)
0 (0%)
5 (71.4%)
5 (33.3%)
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exclusion, and the other surgical drainage. Five of the 
15 patients with iatrogenic perforations died during 
their hospital stay, with a mortality rate of 33.3%.
 Six oesophageal perforations were associated 
with foreign body ingestion (Fig). Three patients 
were treated non-operatively; of the remainder, one 
underwent primary repair, one exclusion, and one 
surgical drainage. None of these patients died during 
hospitalisation.
 Overall, 16 of the 43 patients underwent 
primary repairs in the initial treatment, and four 
(25%) developed clinical signs of leak subsequently. 
All were from Boerhaave’s perforation. Two 
required oesophagectomy while two were managed 
conservatively. 
 Overall, six of the 43 patients underwent 
oesophagectomy, generally as a salvage treatment 
due to failure of other treatment modalities. Three 
patients with Boerhaave’s syndrome required 
oesophagectomy, two with persistent leak after 
primary repair and one with a persistent leak after 
stenting. All had presented >24 hours from symptom 
onset. One patient with a perforated oesophageal 
cancer developed a leak after stenting and required 
oesophagectomy. Two patients with iatrogenic 
perforation in the presence of caustic strictures 
underwent oesophagectomy. Only one patient who 
underwent oesophagectomy died in hospital. 
 Overall, 10 patients died in hospital, with a 
mortality rate of 23.3%. The 30-day mortality rate 
was 16.3%. The median length of hospital stay was 
36.5 days (range, 6-241 days), and median ICU stay 
was 6 days (range, 0-71 days). 
 All 10 patients who died had pre-existing 
oesophageal disease; five had cancer of the 
oesophagus, one caustic stricture, and four had 
oesophageal varices secondary to hepatic cirrhosis. 
Malignant perforation had a substantially higher 
mortality rate of 71.4%. The median survival for 
patients with perforated oesophageal cancer was 
28.5 days (range, 13-848 days). 
 The results of univariate analysis of factors 
potentially associated with hospital mortality are 
shown in Table 3. The presence of pulmonary 
disease, hepatic disease (liver cirrhosis), and 
malignant perforation were significantly associated 
with hospital mortality (P=0.03, <0.01, and <0.01, 
respectively), but the site of perforation and timing 
of presentation were not. 
Discussion
Oesophageal perforation may be difficult to diagnose. 
Patients can present with a wide variety of symptoms, 
which can be non-specific. It is not uncommon 
for the diagnosis to be missed in the acute phase. 
TABLE 3.  Univariate analysis of factors associated with hospital mortality
Factor No mortality (n=33) Mortality (n=10) P value
Median	(range)	age	(years) 66	(30-98) 64	(46-81) 0.80
Sex	(M:F) 20:13 8:2 0.24
Aetiology
Boerhaave’s	syndrome	 15	(45.5%) 0 0.25
Malignant	 2	(6.1%) 5	(50.0%) <0.01
Iatrogenic	 10	(30.3%) 5	(50.0%) 0.25
Foreign	body 6	(18.2%) 0 0.25
Medical	co-morbidity
Cardiac	 16	(48.5%) 5	(50.0%) 0.81
Pulmonary 2	(6.1%) 3	(30.0%) 0.03
Diabetes	mellitus	 4	(12.1%) 3	(30.0%) 0.15
Hepatic	 0 4	(40.0%) <0.01
Location
Cervical	 9	(27.3%) 1	(10.0%) 0.34
Thoracic 21	(63.6%) 9	(90.0%) 0.34
Abdominal 3	(9.1%) 0 0.34
Presentation	
Shock	 6	(18.2%) 4	(40.0%) 0.14
>24	Hours	 9	(27.3%) 5	(50.0%) 0.16
Mechanical	ventilation 3	(9.1%) 2	(20.0%) 0.31
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Computed tomography imaging (preferably with 
oral contrast) should be undertaken when the index 
of clinical suspicion is high, because it allows the site 
of mediastinal or intra-abdominal collections to be 
identified and rules out other pathologies. Of note, 
OGD performed by an experienced endoscopist 
using minimal insufflation is an effective means 
of detecting the site and size of perforation, and is 
reported to have a sensitivity and specificity of 100% 
and 83% for intrathoracic perforation, respectively.17 
A positive OGD therefore has a substantial influence 
on clinical decision making. 
 Spontaneous perforation was the most 
common aetiology in our cohort; around one 
third was associated with underlying cancer of the 
oesophagus. Squamous cell carcinoma remains 
the most common malignant cell type globally, 
despite the rising incidence of adenocarcinoma 
in the western population. Patients often present 
at an advanced stage. Of those patients with 
malignant perforations, all but one had a squamous 
cell carcinoma of the intrathoracic oesophagus. 
Perforation either occurs spontaneously or results 
from concurrent chemoradiotherapy. Ohtsu et 
al18 reported a perforation rate of 13.9% (five out 
of 36 patients) in cases of T4-stage cancer of the 
oesophagus with concurrent chemoradiotherapy. 
In our cohort, perforation occurred shortly after 
completion of radiotherapy in one patient.
 The prognosis for patients with perforated 
oesophageal cancer is poor. The disease is often 
inoperable and in these circumstances treatment 
is palliative.19,20 Non-operative treatment, such as 
insertion of a metallic covered stent, is the usual 
practice at our centre. Stenting of the intrathoracic 
portion of the oesophagus is technically 
straightforward and is successful in most cases. 
Sealing of the perforation site can be confirmed by 
a subsequent contrast study, and oral intake can be 
resumed in the absence of a leak. Nevertheless, the 
prognosis of this group of patients is poor despite 
the successful placement of a stent, and the hospital 
mortality rate remains high. Patients most often 
succumb as a consequence of sepsis caused by the 
perforation. 
 Many treatment options are available for non-
malignant perforation, and the treatment strategy 
should be tailored to the individual. Factors to be 
considered include the site of perforation, extent of 
contamination, pre-existing oesophageal disease, 
and patient co-morbidities. Operative treatment 
is favoured for perforation of the intra-abdominal 
oesophagus or perforation that involves the 
oesophagogastric junction (OGJ). These patients 
often present with abdominal pain and peritonitis. 
Laparotomy, primary repair of the perforation, 
and fashioning of a feeding jejunostomy allow 
alimentation in the event of persistent leak. The 
placement of an oesophageal stent that crosses the 
OGJ has a higher chance of migration and is not 
recommended. 
 The intrathoracic oesophagus is the most 
common site of perforation. Of the three most 
common causes (Boerhaave’s syndrome, iatrogenic 
perforation, and foreign body ingestion), Boerhaave’s 
syndrome is the most challenging. Traditionally, 
Boerhaave’s syndrome is associated with a 
mortality rate of up to 30%.11 Patients may present 
late, the site of perforation is usually at the distal 
thoracic oesophagus, and there may be extensive 
contamination due to the high pressure generated 
by vomiting. Contamination with food particles 
is common. Operative treatment with primary 
closure of the perforation and drainage is favoured 
by many7-9; this is also our preferred approach. Many 
surgeons advocate primary repair irrespective of 
the timing of presentation.9,11,21,22 Leak rates after 
primary repair range from 17% to 32%.9,11,21-24 Minor 
leaks can be managed conservatively with drainage, 
while further surgery (usually exclusion) is required 
for larger leaks and in the presence of sepsis. Lin 
et al23 reported that the incidence of postoperative 
leak was 37.5% in patients in whom treatment was 
delayed for more than 48 hours, compared with 0% 
in those who were treated more promptly. Wright et 
al22 reported that three out of the four leaks in their 
patient cohort were repaired more than 24 hours 
after perforation. The incidence of leak after primary 
repair was 25.0% in our study, which is comparable 
to other reports in the literature. Of the four leaks, 
two patients required reoperation and ultimately 
oesophagectomy; both had presented more than 24 
hours after symptom onset. 
 Endoscopic stenting for benign perforation 
has been reported in several small case series. 
Freeman et al13,14 have reported the outcomes of 
stent placement in patients with iatrogenic and 
spontaneous perforation. They proposed a hybrid 
approach, namely a combination of endoscopic 
and minimally invasive surgical techniques to drain 
intrathoracic and/or intra-abdominal collections. 
The main advantage of this strategy is the avoidance 
of thoracotomy and/or laparotomy. The incidence of 
stent migration was reported to be approximately 
20% in their cohort of patients with spontaneous 
oesophageal perforation.14 Relative contra-
indications to stent insertion include a perforation 
that crosses the OGJ and circumferential necrosis 
of the oesophagus. In our experience, operative 
treatment is recommended for the treatment of 
Boerhaave’s syndrome unless the patient is unfit 
for surgery or declines surgical treatment. Five 
patients in our series initially treated with stenting 
subsequently required surgery, of whom four had 
benign perforations (two with Boerhaave’s syndrome 
and two with iatrogenic perforations). One patient in 
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our cohort with oesophageal dissection complicated 
by perforation underwent stenting in another 
hospital before transferring to our centre; this 
patient developed a persistent leak after stenting. 
In that case, the placement of the stent appeared 
to have aggravated the leak, and oesophagectomy 
was eventually required.25 In our opinion, stent 
placement in benign perforation is only suitable for 
selected patients who present early and have minimal 
contamination. However, stenting may allow more 
time for optimisation of a patient’s condition if they 
are initially judged not to be fit for surgery. 
 Oesophagectomy as a treatment for 
perforations was first reported in the 1950s.26 Single-
stage oesophageal resection and reconstruction 
was first reported by Hendren and Henderson in 
1968.27 Altorjay et al28 reported a hospital mortality 
rate of 3.7% in a series of patients undergoing 
oesophagectomy for intrathoracic perforation; in 
this series iatrogenic perforation represented 55.6% 
of all perforations. Some surgeons have opined that 
oesophagectomy may be superior to primary repair in 
the presence of pre-existing oesophageal disease and 
of extensive perforation with substantial sepsis, while 
the general condition of the patient should always 
be taken into account.28,29 There is no consensus 
about the optimum surgical approach and timing of 
reconstruction after oesophagectomy. We advocate 
primary repair as the initial treatment irrespective 
of the timing of presentation, and oesophagectomy 
is considered a salvage treatment. In our experience, 
patients with persistent leak after primary repair 
and sepsis should undergo oesophageal exclusion 
to control sepsis before oesophagectomy is 
contemplated. Oesophagectomy with primary 
reconstruction can be performed safely after patient 
optimisation. Oesophagectomy was undertaken in 
six patients in our cohort; three of these patients had 
pre-existing oesophageal disease. All patients had 
a cervical oesophagogastric anastomosis fashioned 
via the retrosternal route. A cervical anastomosis 
distant from the infected mediastinum appears to 
be a safe option.29 Thoracotomy is the most common 
surgical approach, but Yeo et al30 reported using 
transhiatal oesophagectomy to treat perforated 
oesophageal cancer in four patients. Thoracotomy 
is avoided in the transhiatal approach, but this 
technique can only be considered in perforations of 
the distal oesophagus and in the presence of minimal 
mediastinal contamination. 
 Oesophageal perforation after foreign body 
ingestion in adults is more common in China as a 
result of its dietary culture. The foreign body is 
usually a fish, chicken, or pork bone. An impacted 
foreign body can usually be retrieved endoscopically; 
however, oesophageal perforation can occur if there 
is deep penetration of the foreign body or extensive 
manipulation during retrieval. The site of perforation 
is usually the cervical oesophagus, followed by the 
intrathoracic oesophagus. In severe cases, operative 
management is indicated; the approach is dependent 
on the site of perforation, and the site and size of 
any collection. The aim of management is to drain 
any collection, remove any residual foreign body, 
repair the perforated site, and protect the airway. In 
the absence of sepsis and imaging appearances of a 
peri-oesophageal collection, conservative treatment 
may be warranted. Operative drainage may be 
necessary if there is a sizeable collection and if there 
is sepsis. Mediastinitis and sepsis are more likely 
after intrathoracic perforation, and would dictate 
treatment strategy.
 It is essential to identify factors associated 
with mortality after oesophageal perforation so 
as to improve treatment and outcomes. Early 
diagnosis and management (in the ‘golden 24 
hours’) are reportedly associated with superior 
outcomes.1,6 Malignant perforation, sepsis, the 
need for mechanical ventilation on presentation, 
and pulmonary co-morbidity are reported to have 
a significant impact on overall survival.5 In our 
cohort, pulmonary co-morbidity, hepatic disease, 
and malignant perforation were associated with risk 
of death. A recent meta-analysis of 75 studies that 
included 2971 patients reported a pooled mortality 
rate of 11.9% (95% confidence interval, 9.7%-14.3%).3 
Of the different aetiologies, spontaneous perforation 
had the highest mortality rate of 14.8%.3 
 Oesophageal perforation remains a difficult 
condition to treat despite advances in surgery, 
endoscopic treatment, and ICU care. The mortality 
rate is still substantial with modern therapies. The 
presence of pre-existing pulmonary disease, hepatic 
disease, and perforation associated with malignancy 
was significantly associated with hospital mortality 
in our cohort. Oesophagectomy for salvage had a 
reasonable success rate in selected patients. 
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